Concepedia

Alasdair Coles

AC

Statistics

Publications

104

Citations

16.9K

H-Index

51

Active since

1996

Affiliations

University of Cambridge(Current)

Addenbrooke's Hospital

University College London

National Hospital for Neurology and Neurosurgery

Queen Mary University of London

Alasdair Coles is an author at University of Cambridge specializing in multiple sclerosis, life sciences, and multiple sclerosis therapy.

ORCID

Publications per year

1996–2024

104

Publications

104

Multiple sclerosis

Alastair Compston, Alasdair Coles · The Lancet · 2008 · 4.3K citations

, , +14

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Jeffrey Cohen, Alasdair Coles, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations

, , +11

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Cary Twyman, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations · Full text

, , +11

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 547 citations · Full text

, , +14

The window of therapeutic opportunity in multiple sclerosis

Alasdair Coles, Amanda Cox, Emmanuelle Le Page et al. · Journal of Neurology · 2005 · 505 citations

, , +14

1–5 of 104